-+ 0.00%
-+ 0.00%
-+ 0.00%

Analysts Have Made A Financial Statement On Jenoptik AG's (ETR:JEN) Second-Quarter Report

Simply Wall St·08/15/2026 06:15:55
Listen to the news

It's been a good week for Jenoptik AG (ETR:JEN) shareholders, because the company has just released its latest quarterly results, and the shares gained 7.3% to €41.98. Jenoptik missed revenue estimates by 4.4%, coming in at€262m, although statutory earnings per share (EPS) of €0.40 beat expectations, coming in 3.6% ahead of analyst estimates. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Jenoptik after the latest results.

earnings-and-revenue-growth
XTRA:JEN Earnings and Revenue Growth August 15th 2026

Following the latest results, Jenoptik's nine analysts are now forecasting revenues of €1.13b in 2026. This would be an okay 7.6% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to ascend 18% to €1.79. Before this earnings report, the analysts had been forecasting revenues of €1.13b and earnings per share (EPS) of €1.76 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

Check out our latest analysis for Jenoptik

It will come as no surprise then, to learn that the consensus price target is largely unchanged at €45.31. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Jenoptik, with the most bullish analyst valuing it at €56.00 and the most bearish at €29.50 per share. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Jenoptik shareholders.

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Jenoptik's rate of growth is expected to accelerate meaningfully, with the forecast 16% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 8.1% p.a. over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 10% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Jenoptik to grow faster than the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at €45.31, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Jenoptik going out to 2028, and you can see them free on our platform here..

It might also be worth considering whether Jenoptik's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here.